1
0
0
News
‘Er is hoop voor kankerpatiënten' | Het Nieuwsblad
www.nieuwsblad.be
‘Moleculaire kankertherapie is de toekomst. Het zorgt voor minder bijwerkingen dan chemo, is efficiënter en bestaat intussen zo goed als voor alle kankers'...
"Met deze nieuwe therapie roeien we kanker uit" - Gazet van Antwerpen
www.gva.be
... kunnen we steeds meer patiënten helpen bij steeds meer verschillende vormen van kanker”, zegt professoroncoloog Ignace Vergote (foto).
Prima BioMed Announces Significant Updates to Its Clinical Advisory...
www.finanznachrichten.de
Prima BioMed Announces Significant Updates to Its Clinical Advisory Board: Eric Pujade-Lauraine, Christian Marth, and Ignace Vergote Join Esteemed Group of Gynecology ...
Alle artikels over "Ignace Vergote" - Data News.be
datanews.knack.be
Alle artikels over het onderwerp
Netzwerk-Profile
LinkedIn: Ignace Vergote | LinkedIn
View Ignace Vergote's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Ignace Vergote discover ...
LinkedIn: Ignace Vergote - Professor - K.U.Leuven | LinkedIn
View Ignace Vergote's profile on LinkedIn, the world's largest professional community. Ignace has 1 job listed on their profile. See the complete profile on ...
LinkedIn: Ignace Vergote | LinkedIn
View Ignace Vergote's (Belgium) professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Ignace Vergote ...
Interessen
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC ...
www.nejm.org
von I Vergote · · Zitiert von: — Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer. List of authors. Ignace Vergote, M.D., Ph.D.,; Claes G. Tropé, ... › doi › full
Gynaecological cancers - The Lancet
www.thelancet.com
— In the first paper in this Series, Ignace Vergote and colleagues present the consensus recommendations from the sixth Gynecologic Cancer ... › series
Gynecologic Oncology Publishes Results of the INNOVATE Phase 2 Pilot...
www.businesswire.com
Novocure announced today that the results of its INNOVATE phase 2 pilot trial have been published in Gynecologic Oncology.
Private Homepages
Steering Committee - IOTA Education
iota.education
— Steering Committee · Dirk Timmerman · Tom Bourne · Lil Valentin · Ben Van Calster · Antonia Testa · Ignace Vergote · Sabine Van Huffel. › about › stee...
Bücher
Dendritic cell-based immunotherapy in ovarian cancer
www.tandfonline.com
von A Coosemans · · Zitiert von: 17 — An Coosemans is a postdoctoral research fellow supported by the FWO-V; Ignace Vergote and Stefaan W Van Gool are senior clinical investigators supported by ... › onci
Atlas of Gynaecological Cancer Surgery (Hardcover)
www.loot.co.za
undefined undefined General, Surgery, Medicine, Books, Gynaecology & obstetrics, Clinical & internal medicine, Gross pathology, Pathology, Other branches of...
: Atlas of Gynaecological Cancer Surgery - Ignace...
www.abebooks.com
Ignace Vergote. Published by Jaypee Brothers Medical Pub (2008). ISBN 10: ISBN 13: New Hardcover Quantity Available: 1.
Proceedings of the International Cancer Imaging Society (ICIS) 16th...
doaj.org
Ignace Vergote (Department of Obstretics and Gynaecology, University Hospitals Leuven) ... of Diagnostic and Interventional Radiology, University Tuebingen)
Dokumente zum Namen
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic...
papers.ssrn.com
Background: Advanced recurrent or metastatic cervical cancer has a 5-year survival of only 17% and no current second-line standard-of-care, representing a signi
Professor Ignace Vergote
www.malmokongressbyra.se
Professor Ignace Vergote is Head of the Department of Obstetrics and Gynaecology and Gynaecologic Oncology at the Catholic University of Leuven, Belgium.
Impact of Adjuvant Chemotherapy and Surgical Staging in ...
academic.oup.com
von JB Trimbos · · Zitiert von: 599 — Ignace Vergote,. Ignace Vergote. Search for other works by this author on: Oxford Academic · PubMed · Google Scholar. Giorgio Bolis,. Giorgio Bolis. › jnci › a...
Neoadjuvant chemotherapy in advanced ovarian cancer
www.gynecologiconcology-online.net
Neoadjuvant chemotherapy in advanced ovarian cancer: What kind of evidence is needed to convince US gynaecological oncologists? Ignace Vergote. › ...
Wissenschaftliche Veröffentlichungen
European Journal of Cancer - ScienceDirect.com
www.sciencedirect.com
von I Vergote · · Zitiert von: 3 — The analysis indicates that the relative clinical benefit of bevacizumab appears to be additive and consistent across regimens. Contributors. Ignace Vergote: ... › pii
Seminars in Oncology | New Developments in Gynecologic Malignancies |...
www.sciencedirect.com
New Developments in Gynecologic Malignancies. Eli Lilly and company. Edited by Robert F. Ozols, Ignace Vergote. Volume 33, Supplement 6, Pages A1-A2, ...
dblp: Artificial Intelligence in Medicine, Volume 28
dblp.uni-trier.de
Bibliographic content of Artificial Intelligence in Medicine, Volume 28
Veröffentlichungen allgemein
bol.com: bol.com | Atlas of Gynaecological Cancer Surgery | |...
Atlas of Gynaecological Cancer Hardcover. Atlas of Gynaecological Cancer Surgery is een boek van Ignace Vergote
The role of interval debulking surgery in ovarian cancer
link.springer.com
von MEL van der Burg · · Zitiert von: 49 — Maria E. L. van der Burg MD, PhD &; Ignace Vergote MD, PhD. Current Oncology Reports volume 5, pages 473–481 (2003)Cite this article Accesses. › article
Hypertension - BioMedSearch
www.biomedsearch.com
Barber Shaun R SR Department of Health Sciences, University of Leicester, United Kingdom Cohen Jay J BMG: The Endocrine Clinic, P.C., South Rex Road, ... Marburg; Pauline Wimberger, AGO and University of Duisburg-Essen, Essen ... Aviano, Italy; Ignace Vergote, Belgian Gynaecological Oncology Group and ...
Video & Audio
NKTR-102: a new drug for treating platinum-resistant or refractory...
ecancer.org
Professor Ignace Vergote speaks about his research into NKTR-102, a new drug for treating women with platinum-resistant/refractory ovarian cancer. In addition t
Artikel & Meinungen
Twitter-Nachrichten: IJGC on Twitter: "@IJGCfellows mentor's #podcast w/ Dr ...
— mentor's #podcast w/ Dr. Ignace Vergote Dr. Vergote talks about: ☑️ his career path ☑️ EORTC ☑️ What he looks for in a gynonc fellow ... › status
Wikipedia: European Society of Gynaecological Oncology – Wikipedia
Die European Society of Gynaecological Oncology (ESGO) ist eine europaweite Vereinigung ... ENGOT, European Network of Gynae Oncological Trial Groups: Ignace Vergote, Belgien. ENTRIGO, European Network of Translational Research ...
Long-term efficacy, tolerability and overall survival in patients...
www.nature.com
Michael Friedlander ,; Ursula Matulonis ,; Charlie Gourley ,; Andreas du Bois ,; Ignace Vergote ,; Gordon Rustin ,; Clare Scott ,; Werner Meier ...
Genome-wide association study identifies a common variant associated...
www.nature.com
Amanda Spurdle and colleagues report results of a genome-wide association study of endometrial cancer. They identify a risk variant near HNF1B that has...
Sonstiges
Ignace Vergote - Google Scholarscholar.google.com › citations
scholar.google.com
Ignace Vergote. Professor of Gynecologic Oncology, University of Leuven. Verified email at uzleuven.be. gynaecological cancer. ArticlesCited byPublic access ...Missing: Oberkirch, Baden" Ignace Vergote. Professor of Gynecologic Oncology, University of Leuven. Verified email at uzleuven.be. gynaecological cancer. ArticlesCited byPublic access ... Missing: Oberkirch, Baden"
Profiles
scholar.google.com
Ignace Vergote. Professor of Gynecologic Oncology, University of Leuven. Verified email at uzleuven.be. Cited by gynaecological cancer ...
NEOADJUVANT CHEMOTHERAPY IN EPITHELIAL OVARIAN CANCER Ateş KARATEKE...
slideplayer.com
Extensive and aggressive surgery improve survival The traditional treatment has consisted of PDS and adjuvant chemotherapy The most important factor regarding...
Alle artikels over "Ignace Vergote" - Belgian Oncology & Hematology...
www.artsenkrant.com
Alle artikels over het onderwerp
Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced...
slideplayer.com
Primary Cytoreductive Surgery Bristow et al JCO % 25mo 75% 34mo
Introduction Ignace Vergote, MD Department of Obstetrics and...
slideplayer.com
Surgery and carboplatin-paclitaxel iv are the cornerstones of first-line therapy 80%-85% respond to first-line therapy Newer regimens including molecular ...
Hoe gaan naar Ignace Vergote in Lubbeek via Bus of Trein?
moovitapp.com
Moovit helpt je de beste route naar Ignace Vergote te vinden met behulp van het openbaar vervoer en geeft je stap-per-stap instructies met actuele uurroosters ...
Ignace Vergote | Research Portal
researchportal.be
Researcher. Ignace Vergote. Keywords:Medicine. Disciplines:Endocrinology and metabolic diseases, Gynaecology and obstetrics, Nursing ...
Tous les articles sur "Ignace Vergote" - Belgian Oncology &...
www.lejournaldumedecin.com
Tous les articles avec le sujet
Professor Ignace Vergote: Current perspectives on...
medicines.astrazeneca.be
Inside Diagnostics Professor Ignace Vergote: Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients. Request your free ...
M.D. Ignace Vergote, Ph.D. » Linkos.cz
www.linkos.cz
University Hospitals Leuven, Katholieke Universiteit Leuven
Verwandte Suchanfragen zu Ignace Vergote
| Werner Meier Philipp Harter |
Personen Vorname "Ignace" (62) Name "Vergote" (20) |
sortiert nach Relevanz / Datum